Russia has signed a deal to produce 10 million doses of the Sputnik V coronavirus vaccine in Italy this year.
The deal was announced Tuesday by the Italian-Russian chamber of commerce. It was signed by Adienne Srl, the Italian subsidiary of a Swiss-based pharmaceutical company, with the Russian Direct Investment Fund.
The Italian-Russian chamber of commerce says Russian authorities are working on 20 similar collaborations across Europe and Sputnik V has been registered in 45 nations worldwide.
The Russian Direct Investment Fund that bankrolled the vaccine and markets it abroad has said the production of Sputnik V will span several countries, including India, South Korea, Brazil, China, Turkey, Iran, as well as Belarus and Kazakhstan. Some manufacturers abroad have produced trial batches of the Russian vaccine, but there are few indications they have so far produced any large amounts of the shot.